AstraZeneca says FDA approves drug for rare kidney disease in adults

Oct 21 (Reuters) - AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its ...
Stocktwits on MSN

AstraZeneca launches targeted lung cancer drug in US after FDA accelerated approval

AstraZeneca (AZN) shares drew investor attention on Thursday after the biopharmaceutical company announced the U.S. launch of ...

AstraZeneca Adds New Indication for Ultomiris Drug in Rare Kidney Disease

AstraZeneca said it received U.S. approval for its Ultomiris drug as a treatment for foamy urine in adults with immunoglobulin A nephropathy, a rare condition that can lead to chronic kidney disease.
AskTraders

AstraZeneca Wins FDA Accelerated Approval for Ultomiris in Rare Kidney Disease

The US regulator has granted Ultomiris accelerated approval in a rare kidney disease, but continued approval hinges on a ...

ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations

AstraZeneca today announced the US availability of ZEGFROVY® (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have ...

AstraZeneca's Ultomiris Wins FDA Approval to Reduce Proteinuria in IgAN Patients

Alexion unit's Ultomiris received the US Food and Drug Administration accelerated approval to reduce proteinuria in adults with primary IgA nephropathy at risk of disease progression, the company said ...
PharmExec

FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy

Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab) has been approved in the U.S. to reduce proteinuria in adults ...
RTTNews

AstraZeneca's Ultomiris Gets FDA Accelerated Approval As First C5 Inhibitor For IgAN

The accelerated approval makes Ultomiris, or ravulizumab, the first and only C5 complement inhibitor approved for this use. Novartis' Fabhalta, or iptacopan, is also approved for this indication but ...
Mint

US FDA approves AstraZeneca’s new breast cancer pill Etcamah: Dosage, high risk and side effects — All you need to know

The US Food and Drug Administration (FDA) said on Friday it granted accelerated approval to AstraZeneca Plc’s breast cancer pill, expanding treatment options for adult patients with advanced breast ...
Morningstar%2c Inc.

AstraZeneca hails tozorakimab licence application approval in US

(Alliance News) - AstraZeneca PLC on Tuesday said its biologics licence application for tozorakimab in the US was accepted under priority review. The Cambridge, England-based pharmaceutical company ...
Morningstar%2c Inc.

AstraZeneca says lupus treatment gets US FDA approval

(Alliance News) - AstraZeneca PLC on Monday said its self-administered lupus treatment has been approved in the US. The US Food & Drug Administration has approved the Saphnelo Pen once-weekly ...